Anavex life sciences -fast track designation granted by fda for rett syndrome treatment

Anavex life sciences announces fast track designation granted by u.s. fda for anavex®2-73 (blarcamesine) clinical development program for the treatment of rett syndrome.

AVXL Ratings Summary

AVXL Quant Ranking